Jack Barber work email
- Valid
- Valid
- Valid
Jack Barber personal email
Jack Barber phone numbers
➢ Ph.D. in Biochemistry from UCLA and a post doctoral fellowship at The Salk Institute for Biological Studies➢ Lecture and laboratory teaching experience with college-level general, organic, and biological chemistry and tutoring experience with high school and college biology and chemistry. An experienced, professionally trained public speaker for all educational levels ➢ Over 20 years in biopharmaceutical R&D (drugs and biologics), including fourteen years executive management experience (Vice President and above) leading and integrating multi-functional departments of up to 70 employees with over $25M annual operating budgets. A proven track record prioritizing, optimizing, selecting, and advancing therapeutic leads from research into clinical development. Demonstrated ability to compete for government grant support➢ Co-author of over 50 peer-reviewed publications and inventor of over 20 issued patents, with numerous additional patent applications pending➢ Operationally versatile, having been responsible for establishing and leading multiple departments in the drug development process: Drug discovery R&D from target identification and validation, through chemical library cell based and protein-based screening (HTS and HCS), hit-to-lead optimization, proof of concept pharmacodynamics and mechanism of action, and pre-clinical safety pharmacology and toxicokinetics GMP Manufacturing; Responsible for in-house and contract manufacture of drugs and biologics used in clinical trials. Prior “Pharmacy Exemptee” certification from California State Board of Pharmacy. Responsible for CMC Quality Assurance/Quality Control; Successfully set up quality system for GMP manufacturing and obtained site-specific California State Investigational Drug Manufacturing License Clinical Development and Regulatory Affairs; Protocol design, Clinical Operations, CRO management, preparation, submission, and amendments to 9 IND applications, drugs and biologics, through Phase IIb
Independent Instructor
-
Adjunct Professor And TutorIndependent Instructor Jan 2010 - PresentSan Diego, Ca• Four semesters as an instructor at Southwestern Community College, teaching general (Chem 100), analytical (Chem 250), and organic and biological chemistry (Chem 110). • Prior to that an independent chemistry and biology tutor of individual high school and college undergraduate students.
-
Chief Scientific OfficerCytrx Mar 2004 - Dec 2010Los Angeles, CaliforniaSUMMARY: As an officer of this public biopharmaceutical company, was a major contributor rebuilding the company from its restart in mid-2003. Helped increase company market capitalization from $40M at the time I joined in July 2004 to approximately $140M when I left the company in December 2009.CHIEF SCIENTIFIC OFFICER AND SENIOR VICE PRESIDENT, DRUG DEVELOPMENT• In charge of overall discovery, preclinical, and clinical research of small molecule drugs for cancer, neurodegenerative diseases, Stroke, and Diabetic complications, including specific therapies for diabetic ulcers and peripheral neuropathy)• Responsible for building a discovery research laboratory from site identification and negotiation of the lease to a fully operational laboratory a scientific staff of 9 chemists, 9 biologists, and 4 clinical and regulatory professionals. Accomplishments include multiple scientific publications and patent applications• Responsible for scientific and strategic evaluation of M&A and in-licensing opportunities, including the October, 2004 acquisition of the clinical and intellectual property assets of Biorex Research and Development Company including three clinical stage oral drug candidates and the June 2008 acquisition of Innovive Pharmaceuticals with four clinical stage oncology products including one that is currently in a pivotal clinical trial• Responsible for strategic realignment of company assets, focusing internal resources away from RNAi therapeutics to oral drugs for chaperone amplification and inhibition• In charge of preclinical, manufacturing, regulatory, and clinical development of the drug arimoclomol for the treatment of ALS, including planning and successful completion of five Phase I studies, a Phase IIa, and Phase IIa open-label extension. • Responsible for preclinical development and IND preparation for a planned phase IIa clinical trial for diabetic foot ulcers with the drug candidate iroxanadine. -
Vice President R&D And Chief Technical OfficerImmusol 1995 - 2003San Diego, CaliforniaAs an officer of the company and its third employee, I was a major contributor to building the company and increasing its (private) capitalization by over 50-fold. CHIEF TECHNICAL OFFICER & VICE PRESIDENT R&D (2001-2003) • Established two R&D facilities and led a multi-functional department of up to 70 people and seamlessly integrated multiple drug target discovery and validation programs (cancer, viral, neurodegenerative disease, and obesity/diabetes) and therapeutic programs (cardiovascular, skin, and eye disease) into a cohesive strategic matrix• Responsible for establishing and maintaining drug discovery alliances with Novartis ($150M), Pfizer ($50M), Chugai, and Medarex• Invented and implemented the Company’s platform technology “Inverse Genomics” • Successfully expanded the company intellectual property portfolio, and met milestones for corporate partnerships, resulting in contract extensions. Established Company’s IP strategy with involvement throughout the process from writing to issuance• Responsible for pre-clinical drug evaluation supporting the Clinical Affairs department with IND preparation for a Phase II clinical trial for Proliferative Vitreoretinopathy, and a phase Ib clinical trial for hypertrophic scarring. Previously directly responsible for Regulatory Affairs, preparing, submitting, and supporting the Company’s lead IND application for gene therapy of AIDS, resulting in a Phase Ib clinical trial• Responsible for GMP drug manufacturing, certified "Pharmacy Exempt" by the California State Board of Pharmacy, required for state-approved GMP drug manufacturing• Established and directed the QA/QC department, leading to issuance of the company’s Investigational Drug Manufacturing License by the State of California (License # 41658, 1997-2000)• Financed operations through competitive grants, awarded over $4M from the NIH and DOE -
Associate Director, OncologyViagene 1988 - 1994La JollaAs one of the company’s first principle scientists, helped establish the world’s first gene therapy company and position it for acquisition by Chiron.ASSOCIATE DIRECTOR, ONCOLOGY • Managed a pre-clinical staff of six people, while in charge of the inter-departmental project team responsible for the clinical development of the company’s lead cancer immunotherapeutic program that established the corporate alliance with, and ultimately the acquisition by, Chiron • Conceived, initiated, directed, and patented several immunotherapeutic approaches to cancer treatment (melanoma, breast, and colon), from initial proof-of-concept feasibility studies through to writing the Investigator Brochure, Pharmacology, and Chemistry, Manufacturing, and Control sections of the INDs, leading to the initiation of two published Phase Ib clinical trials for cancer immunotherapy • Generation and molecular and cellular characterization of product manufacturing cell lines for Master File submission• Managed a staff of 8, responsible for product development of the Company’s lead immunotherapeutic drug candidate used in several published AIDS clinical trials• Initiated and directed a multidisciplinary assay development group that developed and validated assays for QA/QC product release testing• Supervised a group of 3 people, establishing the therapeutic potential of regulated expression of conditionally lethal genes using tissue-specific transcriptional promoters for AIDS and cancer, ultimately resulting in issued patents and a published cancer clinical trial
-
Post-Doctoral FellowSalk Institute For Biological Studies 1984 - 1988La JollaPost-doctoral fellow conducting independent research on the role of oncoprotein phosphorylation in controlling tumorigenesis and gene expression using protein chemistry, molecular biology, site-directed mutagenesis, and gene transfer
Jack Barber Skills
Jack Barber Education Details
-
Biochemistry
Frequently Asked Questions about Jack Barber
What company does Jack Barber work for?
Jack Barber works for Independent Instructor
What is Jack Barber's role at the current company?
Jack Barber's current role is Instructor of Chemistry, Biology, and Biochemistry.
What is Jack Barber's email address?
Jack Barber's email address is ja****@****.rr.com
What is Jack Barber's direct phone number?
Jack Barber's direct phone number is +131082*****
What schools did Jack Barber attend?
Jack Barber attended University Of California, Los Angeles, Ucla.
What skills is Jack Barber known for?
Jack Barber has skills like Higher Education, Drug Discovery, Biotechnology, Biochemistry, Molecular Biology, Immunology, Pharmacology, Clinical Development, Oncology, Cancer, Protein Chemistry, Clinical Trials.
Not the Jack Barber you were looking for?
-
Jack Barber
Partner, Litigation & Trials | Securities & Professional Liability | White Collar Defense & InvestigationsChicago, Il -
Jack Barber
San Mateo, Ca1extend.cl -
-
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial